Patients usually ask about retatrutide after tirzepatide results have stalled
GLP-1 for food cravings: They reduce food-related thoughts and the dopamine-driven desire to overeat
GLP-1 medications mimic the hormone GLP-1 in the body
Given the cardiovascular and renal benefits of GLP-1 receptor agonists, how do these effects expand their use beyond glycemic control in patients with metabolic disorders
Advertising Restrictions Regulation 279 of the Human Medicines Regulations restricts advertising a medicinal product where the required marketing authorisation, registration or certificate is not in force
Once the adipose tissue expandability exceeded limit under overnutrition, excess lipids and toxic lipid metabolites (FFA, diacylglycerol, ceramide) accumulated in non-adipose tissues, thus leading to lipid-induced toxicity (lipotoxicity) and developed IR in liver and muscle